Greg Roberts

Greg Roberts currently serves as VP - Global Development Lead at Apollo Therapeutics, overseeing teams in the discovery and development of oncology drugs. Previously, Roberts held the position of VP - Asset Strategy Lead for Oncology at AbbVie, managing early and late-stage oncology program development. A long tenure at Pfizer included roles such as Global Medicine Team Lead for Oncology, where Roberts led oncology biosimilar portfolio development, and Head of Portfolio & Development Strategy for the Centers for Therapeutic Innovation. Early academic contributions as an Assistant Professor at the University of California, San Diego focused on tumor vascular biology. Greg Roberts holds multiple advanced degrees, including a Ph.D. in Developmental & Cell Biology from UC Irvine and an MBA from the University of Rhode Island.